Open Access 01-12-2010 | Research
Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design
Published in: Behavioral and Brain Functions | Issue 1/2010
Login to get access